Trial intelligence / Profile preview

Dexmedetomidine on Renal Function After Kidney Transplantation

NCT03327389Unknown

Sponsor
Yonsei University
Start
Nov 2017
Primary completion
Sep 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of dexmedetomidine in delayed graft function (DGF) (2 arms), sponsored by Yonsei University. Primary endpoint: Serum creatinine level. Status: unknown.

02

Drugs

dexmedetomidine
03

Conditions

delayed graft function (DGF)

Beyond the preview

Go deeper on NCT03327389.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03327389.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call